Patents by Inventor Marieke Lansbergen

Marieke Lansbergen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20170157163
    Abstract: The invention pertains to the use of (i) one or more of uridine and cytidine, or salts, phosphates, acyl derivatives or esters thereof, and (ii) a lipid fraction comprising at least one of docosahexaenoic acid (22:6; DHA), eicosapentaenoic acid (20:5; EPA) and docosapentaenoic acid (22:5; DPA), or esters thereof in the manufacture of a composition for use in a method for treating, stabilizing or slowing down brain glucose metabolism deficit in a subject in need thereof.
    Type: Application
    Filed: February 2, 2015
    Publication date: June 8, 2017
    Applicant: N.V. Nutricia
    Inventors: Maria Ladislaus BROERSEN, Robert Johan Joseph HAGEMAN, Marieke LANSBERGEN, Martine GROENENDIJK, Mattheus Cornelis DE WILDE
  • Publication number: 20150044138
    Abstract: The invention relates to a composition comprising: (i) one or more of uridine and cytidine, or salts, phosphates, acyl derivatives or esters thereof; and (ii) a lipid fraction comprising at least one of docosahexaenoic acid (22:6; DHA), eicosapentaenoic acid (20:5; EPA) and docosapentaenoic acid (22:5; DPA), or esters thereof, for use in preserving or improving functional synaptic connectivity and/or preserving brain network organization in a subject in need thereof.
    Type: Application
    Filed: March 4, 2013
    Publication date: February 12, 2015
    Applicant: N.V. Nutricia
    Inventors: Marieke Lansbergen, Martine Groenendijk, Patrick Joseph Gerardus Hendrikus Kamphuis, Mattheus Cornelis De Wilde